Showing results (11-20 of 25) with videos related to
Sort By:
Pageof 3
Cell Death & Disease|August 29, 2014
Combination of lenalidomide with vitamin D3 induces apoptosis in mantle cell lymphoma via demethylation of BIKC Brosseau, C Dousset, C Touzeau, et al.Leukemia|August 30, 2002
Farnesyl transferase inhibitor R115777 induces apoptosis of human myeloma cellsS Le Gouill, C Pellat-Deceunynck, J-L Harousseau, et al.Leukemia Research|June 27, 2000
Reactive plasmacytoses in multiple myeloma during hematopoietic recovery with G- or GM-CSFG Jego, H Avet-Loiseau, N Robillard, et al.British Journal of Cancer|May 2, 2013
Paradoxical effect of lenalidomide on cytokine/growth factor profiles in multiple myelomaS Maïga, P Gomez-Bougie, S Bonnaud, et al.European Journal of Immunology|March 31, 2000
The cancer germ-line genes MAGE-1, MAGE-3 and PRAME are commonly expressed by human myeloma cellsC Pellat-Deceunynck, M P Mellerin, N Labarrière, et al.Blood|October 15, 1994
Expression of CD28 and CD40 in human myeloma cells: a comparative study with normal plasma cellsC Pellat-Deceunynck, R Bataille, N Robillard, et al.Blood|July 9, 1999
Reactive plasmacytoses are expansions of plasmablasts retaining the capacity to differentiate into plasma cellsG Jego, N Robillard, D Puthier, et al.Blood Reviews|March 13, 2017
p53 dysregulation in B-cell malignancies: More than a single gene in the pathway to hellB Tessoulin, M Eveillard, A Lok, et al.British Journal of Cancer|November 11, 2010
BH3-only protein Bik is involved in both apoptosis induction and sensitivity to oxidative stress in multiple myelomaL Bodet, E Ménoret, G Descamps, et al.Leukemia|February 20, 1999
Differential expression of Bcl-2 in human plasma cell disorders according to proliferation status and malignancyD Puthier, C Pellat-Deceunynck, S Barillé, et al.Pageof 3